E998: The Next Unicorns: Benchling CEO & Co-founder Sajith Wickramasekara is increasing efficiency for scientists with a cloud-based platform, gives insights on recent life-science innovations, ethics of gene therapy & defining the line between quackery & brilliance – E10 of 10-ep miniseries
55 min•6 november 2019
0:53 Jason intros Sajith Wickramasekara
1:40 What does Benchling do?
2:24 How did Sajith get into life science?
6:55 Benchling's value proposition for scientists
9:04 How do they charge?
10:43 Is Chamath Palihapitiya the most famous Sri Lankan in the US?
13:25 Why immunotherapy is the most exciting development in life science
19:00 3D Printing & harvesting organs in other species
20:50 Ethics of editing a human embryo
28:19 How did the scientific community respond to the embryo controversy
29:52 Breakthroughs in gene therapy
34:09 Defining the line between quackery & brilliance
42:37 Upside & downside of genetically modified crops
47:54 What is the best approach for breakthroughs in life science?
1:40 What does Benchling do?
2:24 How did Sajith get into life science?
6:55 Benchling's value proposition for scientists
9:04 How do they charge?
10:43 Is Chamath Palihapitiya the most famous Sri Lankan in the US?
13:25 Why immunotherapy is the most exciting development in life science
19:00 3D Printing & harvesting organs in other species
20:50 Ethics of editing a human embryo
28:19 How did the scientific community respond to the embryo controversy
29:52 Breakthroughs in gene therapy
34:09 Defining the line between quackery & brilliance
42:37 Upside & downside of genetically modified crops
47:54 What is the best approach for breakthroughs in life science?
Fler avsnitt av This Week in Startups
Visa alla avsnitt av This Week in StartupsThis Week in Startups med Jason Calacanis finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.